FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
Despite getting lumped in with the Herbalife debate, Nu Skin Enterprises' (NYSE: NUS) remains in the "in the midst of a powerful product cycle," according to analyst at Canaccord Genuity. The firm reiterated a Buy rating but trimmed their price target from $65 to $55.... More

